Showing 12,001 - 12,020 results of 133,941 for search '(( 2 c decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.24s Refine Results
  1. 12001

    NBCe1 protein expression regulation by D<sub>1</sub>-like (D<sub>1</sub>R and D<sub>5</sub>R) dopamine receptor agonist in hRPTCs carrying wild-type (WT) <i>SLC4A5</i>. by John J. Gildea (845025)

    Published 2018
    “…<p>NBCe1 protein expression is decreased following an increase in intracellular sodium (↑Na<sup>+</sup>) (10 μmol monensin/L, 24 h) (N = 4, *P<0.001 vs VEH, one-way ANOVA, Tukey’s test) in WT <i>SLC4A5</i> hRPTC. …”
  2. 12002

    Dopamine decreases the refractive power in the lens periphery. by J. Marcus Schartau (365288)

    Published 2013
    “…Positive ΔBCD values indicate a decrease in refractive power <i>i.e.</i> an increase in BCD in the treated lens compared with the corresponding control lens from the same animal. …”
  3. 12003
  4. 12004

    Serotonin Receptor 2C and Insulin Secretion by Qiang Zhang (45005)

    Published 2013
    “…However, it is known that the 5-HT receptor 2C (5-HT<sub>2C</sub>R) agonist, mCPP, decreases plasma insulin concentration in mice. …”
  5. 12005
  6. 12006
  7. 12007
  8. 12008

    Data_Sheet_2_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu... by Yize Li (471459)

    Published 2022
    “…Artesunate normalized paclitaxel-related expression changes in DRG mGluR5, NR1, and GluA2, as well as six paclitaxel related neuroinflammation markers. …”
  9. 12009

    Data_Sheet_1_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu... by Yize Li (471459)

    Published 2022
    “…Artesunate normalized paclitaxel-related expression changes in DRG mGluR5, NR1, and GluA2, as well as six paclitaxel related neuroinflammation markers. …”
  10. 12010

    Data_Sheet_6_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu... by Yize Li (471459)

    Published 2022
    “…Artesunate normalized paclitaxel-related expression changes in DRG mGluR5, NR1, and GluA2, as well as six paclitaxel related neuroinflammation markers. …”
  11. 12011

    Data_Sheet_3_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu... by Yize Li (471459)

    Published 2022
    “…Artesunate normalized paclitaxel-related expression changes in DRG mGluR5, NR1, and GluA2, as well as six paclitaxel related neuroinflammation markers. …”
  12. 12012

    Data_Sheet_4_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu... by Yize Li (471459)

    Published 2022
    “…Artesunate normalized paclitaxel-related expression changes in DRG mGluR5, NR1, and GluA2, as well as six paclitaxel related neuroinflammation markers. …”
  13. 12013
  14. 12014
  15. 12015
  16. 12016

    Release-decreasing vs. release-increasing astrocytes. by Maurizio De Pittà (194237)

    Published 2011
    “…The global change of the amount of released resources is accompanied also by local changes in terms of paired-pulse plasticity. (<b>C</b>) For the depressing synapse with release-decreasing astrocyte in (<b>A</b>), the ratio between facilitated (PPF) and depressed (PPD) spike pairs, increases in favor of the former. …”
  17. 12017

    Table_2_Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico.docx by Lenin Domínguez-Ramírez (481547)

    Published 2022
    “…Our analysis suggests that the vaccination strategy in Mexico has been successful to limit population mortality and decrease severe COVID-19, but children in Mexico still need access to SARS-CoV-2 vaccines to limit severe COVID-19, in particular those 1–4 years old.…”
  18. 12018

    Table_1_Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico.docx by Lenin Domínguez-Ramírez (481547)

    Published 2022
    “…Our analysis suggests that the vaccination strategy in Mexico has been successful to limit population mortality and decrease severe COVID-19, but children in Mexico still need access to SARS-CoV-2 vaccines to limit severe COVID-19, in particular those 1–4 years old.…”
  19. 12019
  20. 12020

    <sup>13</sup>C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…Additionally, it effectively lowers serum cholesterol levels by as much as 69.2% and low-density lipoprotein cholesterol (LDL-C) levels by up to 88.2% in the MASH mouse model. …”